Distal Pancreatectomy with Splenectomy
The common indications of distal pancreatectomy include localized adenocarcinoma in this area, islet cell adenomas, cysts, and chronic calcific pancreatitis. With the popularization of laparoscopic technique in pancreatic surgery, there is no significant difference in the perioperative safety between minimally invasive distal pancreatectomy (MIDP) and open procedure distal pancreatectomy (ODP) [1, 2]. However, the long-term survival benefit of MIDP for pancreatic malignancy needs to be further confirmed by more research . Therefore, the ODP is still a standard procedure for the resection of pancreatic adenocarcinoma located in the body and tail of pancreas.
- 1.van Hilst J, Strating EA, de Rooij T, Daams F, Festen S, Groot Koerkamp B, Klaase JM, Luyer M, Dijkgraaf MG, Besselink MG, Dutch Pancreatic Cancer G and Collaborators Lt. Costs and quality of life in a randomized trial comparing minimally invasive and open distal pancreatectomy (LEOPARD trial). Br J Surg. 2019;106(7):910–21.CrossRefGoogle Scholar
- 2.van Hilst J, Korrel M, de Rooij T, Lof S, Busch OR, Groot Koerkamp B, Kooby DA, van Dieren S, Abu Hilal M, Besselink MG, Group Ds. Oncologic outcomes of minimally invasive versus open distal pancreatectomy for pancreatic ductal adenocarcinoma: a systematic review and meta-analysis. Eur J Surg Oncol. 2019;45(5):719–27.CrossRefGoogle Scholar